Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010

Authors

Seyed Mohammad Ebrahim Tahaei1, Seyed Reza MohebbiSeyed Reza Mohebbi ORCID2,*, Pedram Azimzadeh1, Mohsen Vahedi1, Shohreh Almasi1, Sara Romani1, Afsaneh Sharifian1, Faramarz Derakhshan1, Mohammad Reza Zali1
1Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, IR Iran
2Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, [email protected], IR Iran
*Corresponding Author: Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, [email protected], IR Iran. Tel: +98-2122432514. Fax: +98-2122432515. Email: [email protected]

Hepatitis Monthly:Vol. 11, issue 12; 993-996
Published online:Dec 31, 2011
Article type:Brief Report
Received:Jun 18, 2011
Accepted:Jul 20, 2011
How to Cite:Ebrahim Tahaei SM, Mohebbi S, Azimzadeh P, Vahedi M, Almasi S, et al. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011;11(12):. doi: https://doi.org/10.5812/kowsar.1735143X.740

Abstract

Background: Co-infection with hepatitis C virus (HCV) and/or human immunodeficiency virus (HIV) in patients with chronic hepatitis B virus (HBV) infection can alter the course of the disease.
Objectives: In this study, we investigated the frequency of HIV and/or HCV co-infection in chronic HBV patients and related risk factors in acquiring the HCV and or HIV co-infectionit.
Patients and Methods: We studied 264 chronic HBV patients who visited the Gastrointestinal and Liver Ward of the Taleghani Hospital, Tehran, Iran between 2006 and 2010. Demographic information and records of possible risky behavior were obtained. Antibodies against HBV, HCV, and HIV, levels of alanine transaminase (ALT) and aspartate transaminase (AST), and conversion from hepatitis B e antigen (HBeAg) to hepatitis B e antibody (HBeAb) were evaluated.
Results: Of 264 patients with chronic HBV in this study, 184 patients (70%) were men and 78 patients (30%) were women. Only 1 patient (0.37%) was positive for anti-HIV antibody, whereas 12 patients (4.54%) were positive for anti-HCV antibody. None of the patients had co-infection with all 3 viruses (HBV, HIV, and HCV).
Conclusions: This study demonstrated that the prevalence of HCV is higher than that of HIV in chronic HBV patients. Since HCV or HIV co-infection affects the therapeutic outcome in chronic HBV patients, testing for HIV and HCV is recommended, especially for patients with a history of risky behavior.


Implication for health policy/practice/research/medical education:
Readers of this manuscript will realize that Hepatitis C virus and Human Immunodeficiency virus co-infections have important impacts on the management of hepatitis B chronic patients. In addition this study will attract the attention of health policy-makers towards some routes of infection transfer like periodontal procedures, which generally are ignored, but need to be monitored more strictly.

Please cite this paper as:
Tahaei SMe, Mohebbi SR, Azimzadeh p, Vahedi M, Almasi S, Romani S, et al. Frequency of HIV and HCV Co-Infections in Chronic HBV patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011;11(12):993-6. DoI: 10.5812/kowsar.1735143X.740


Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Sep
2010

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors

Behrooz Ataei,
Katayoon Tayeri,
Ziba Farajzadegan,
Anahita Babak,
Nazila Kassaian

Ataei B, Tayeri K, Farajzadegan Z, Babak A, Kassaian N. Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors. Hepat Mon. 2010;10(3):. doi:

20
Apr
2020
Prevalence of HBV/HCV Co-Infection and Associated Risk Factors in People Living with HIV

Prevalence of HBV/HCV Co-Infection and Associated Risk Factors in People Living with HIV

Sevtap Senoglu,
Zuhal Yesilbag,
Hayat Kumbasar Karaosmanoglu,
Ozlem Altuntas Aydin

Senoglu S, Yesilbag Z, Kumbasar Karaosmanoglu H, Altuntas Aydin O. Prevalence of HBV/HCV Co-Infection and Associated Risk Factors in People Living with HIV. Hepat Mon. 2020;20(4):e98594. doi: https://doi.org/10.5812/hepatmon.98594

5
Jun
2016

Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran

Hasan Afzali,
Mansooreh Momen-Heravi,
Asefeh Farokhzad

Afzali H, Momen-Heravi M, Farokhzad A. Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran. Hepat Mon. 2016;16(7):e30459. doi: https://doi.org/10.5812/hepatmon.30459

23
Apr
2015

Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran

Mohammad Ali Davarpanah,
Nasrin Motazedian,
Ebrahim Fallahzadeh,
Maryam Rasti,
Hashem Rahmati,
Nadia Motazedian

Davarpanah MA, Motazedian N, Fallahzadeh E, Rasti M, Rahmati H, et al. Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran. Shiraz E-Med J. 2015;16(4):e24676. doi: https://doi.org/10.17795/semj24676

2
May
2016

Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran

Mohammad Reza Hasanjani Roushan,
Safa Farokhtabar,
Masomeh Bayani,
Sepideh Siadati

Hasanjani Roushan MR, Farokhtabar S, Bayani M, Siadati S. Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran. Nephro-Urol Mon. 2016;8(3):e37878. doi: https://doi.org/10.5812/numonthly.37878

More by these authors

Seyed Mohammad Ebrahim TahaeiPubMedScholar
Seyed MohebbiPubMedScholar
Pedram AzimzadehPubMedScholar
Mohsen VahediPubMedScholar
Shohreh AlmasiPubMedScholar
Sara RomaniPubMedScholar
Afsaneh SharifianPubMedScholar
Faramarz DerakhshanPubMedScholar
Mohammad ZaliPubMedScholar
Share
Cited by
Metrics